The mission of the CRAB Clinical Trials Consortium is to create a focused, world-wide cancer clinical trials group that will centralize, prioritize and accelerate the clinical development of the most promising agents for patients with cancer.
CRAB®’s approach to curing cancer is to collaborate with investigators to design, implement, and execute clinical trials such that reliable and replicable results are obtained.
The CRAB CTC consortium is comprised of pre-eminent member investigators who share the vision of making significant advances available to cancer patients as efficiently as possible.
For sponsors seeking a focused, well-coordinated investigational network that can expedite the clinical development of promising new cancer therapies, CRAB CTC is pleased to provide our support.
To download a brochure in pdf file format please click on the image.
The CRAB CTC provides a central resource for investigators wishing to explore and become involved with the clinical development of novel intervention.
CTC is built upon decades of clinical trials management experience at CRAB..
Contract research services available from CRAB include. . .
Services of CRAB’s Clinical Trials Consortium include. . .